• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经颈静脉肝内门体分流术治疗门静脉血栓形成:文献综述

Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature.

作者信息

Qi Xingshun, Han Guohong

机构信息

Fourth Military Medical University, Xijing Hospital of Digestive Diseases, 15 West Changle Road, Xi'an, 710032, China.

出版信息

Hepatol Int. 2012 Jun;6(3):576-90. doi: 10.1007/s12072-011-9324-5. Epub 2011 Dec 1.

DOI:10.1007/s12072-011-9324-5
PMID:26201472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7101972/
Abstract

Reports of successful transjugular intrahepatic portosystemic shunt (TIPS) surgery in patients with portal vein thrombosis (PVT) are considered anecdotal owing to the technical difficulty of the procedure and potential procedure-related complications. A literature review was undertaken to determine the feasibility and safety of TIPS in the treatment of PVT. All studies in which TIPS was attempted in patients with PVT were identified by searching through the PUBMED and MEDLINE databases. A total of 424 PVT patients undergoing TIPS were reported in 54 articles. The success rate of TIPS insertion was 67-100% in 19 case series. Further, 85 patients with portal cavernoma underwent successful TIPS insertions. Three therapeutic strategies of TIPS placement were used: (1) TIPS placement followed by portal vein recanalization via the shunt, (2) portal vein recanalization via percutaneous approaches followed by TIPS placement, and (3) TIPS insertion between a hepatic vein and a large collateral vessel without portal vein recanalization. Four approaches were used to access the portal vein: transjugular, transhepatic, transsplenic, and transmesenteric. Intra-abdominal hemorrhage secondary to hepatic capsule perforation was lethal in only three patients. No episode of pulmonary embolism was reported. Other procedure-related complications were reversible. The overall incidence of shunt dysfunction and hepatic encephalopathy was 8-33% and 0-50%, respectively. In conclusion, the reviewed studies uniformly support the feasibility and safety of TIPS for PVT even in the presence of portal cavernoma. Further, several major issues that remain unresolved are discussed.

摘要

由于经颈静脉肝内门体分流术(TIPS)操作技术难度大以及存在潜在的与手术相关的并发症,门静脉血栓形成(PVT)患者成功进行TIPS手术的报道被认为是个案。进行了一项文献综述,以确定TIPS治疗PVT的可行性和安全性。通过检索PUBMED和MEDLINE数据库,确定了所有尝试对PVT患者进行TIPS的研究。54篇文章报道了总共424例接受TIPS的PVT患者。在19个病例系列中,TIPS置入成功率为67%-100%。此外,85例门静脉海绵样变性患者成功进行了TIPS置入。采用了三种TIPS放置治疗策略:(1)TIPS放置后通过分流道进行门静脉再通;(2)经皮途径进行门静脉再通后进行TIPS放置;(3)在肝静脉和大的侧支血管之间插入TIPS而不进行门静脉再通。采用了四种进入门静脉的方法:经颈静脉、经肝、经脾和经肠系膜。仅3例患者因肝包膜穿孔继发腹腔内出血死亡。未报告肺栓塞事件。其他与手术相关的并发症是可逆的。分流功能障碍和肝性脑病的总体发生率分别为8%-33%和0%-50%。总之,综述研究一致支持TIPS治疗PVT的可行性和安全性,即使存在门静脉海绵样变性。此外,还讨论了几个尚未解决的主要问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7101972/3417fa390b6b/12072_2011_9324_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7101972/610673cc1b8e/12072_2011_9324_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7101972/92b649111ef4/12072_2011_9324_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7101972/551b856c4bb5/12072_2011_9324_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7101972/98c816b6422e/12072_2011_9324_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7101972/3417fa390b6b/12072_2011_9324_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7101972/610673cc1b8e/12072_2011_9324_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7101972/92b649111ef4/12072_2011_9324_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7101972/551b856c4bb5/12072_2011_9324_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7101972/98c816b6422e/12072_2011_9324_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7101972/3417fa390b6b/12072_2011_9324_Fig5_HTML.jpg

相似文献

1
Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature.经颈静脉肝内门体分流术治疗门静脉血栓形成:文献综述
Hepatol Int. 2012 Jun;6(3):576-90. doi: 10.1007/s12072-011-9324-5. Epub 2011 Dec 1.
2
Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.经皮经肝球囊辅助经颈静脉肝内门体分流术治疗慢性、完全闭塞性门静脉血栓形成伴症状性门静脉高压:操作技术、安全性和临床应用。
Eur Radiol. 2015 Dec;25(12):3431-7. doi: 10.1007/s00330-015-3777-1. Epub 2015 Apr 23.
3
[Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].经颈静脉肝内门体分流术联合经皮经肝或经脾途径治疗伴或不伴海绵样变性的门静脉血栓形成
Zhonghua Yi Xue Za Zhi. 2009 Jun 9;89(22):1549-52.
4
Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients.经颈静脉肝内门体分流术治疗非肝硬化患者伴症状性门静脉高压的门静脉海绵样变性。
Dig Dis Sci. 2012 Apr;57(4):1072-82. doi: 10.1007/s10620-011-1975-5. Epub 2011 Dec 7.
5
Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations.门静脉再通及经颈静脉肝内门体分流术治疗慢性门静脉血栓形成:技术要点
Tech Vasc Interv Radiol. 2016 Mar;19(1):52-60. doi: 10.1053/j.tvir.2016.01.006. Epub 2016 Feb 6.
6
Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis.慢性非肝硬化、非恶性门静脉血栓形成患者经颈静脉门静脉再通并建立肝内门体分流术(PVR-TIPS)
Z Gastroenterol. 2018 Mar;56(3):221-237. doi: 10.1055/s-0043-121348. Epub 2017 Nov 7.
7
Percutaneous Transsplenic Balloon-Assisted Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Portal Vein Obliteration for Portal Vein Recanalization: Feasibility, Safety and Effectiveness.经皮经脾球囊辅助经颈静脉肝内门体分流术在门静脉闭塞患者中的应用:门静脉再通的可行性、安全性和有效性。
Cardiovasc Intervent Radiol. 2022 May;45(5):696-702. doi: 10.1007/s00270-021-03054-2. Epub 2022 Jan 11.
8
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.经颈静脉肝内门体分流术治疗肝硬化门静脉血栓形成伴静脉曲张出血:一项前瞻性队列研究的结果及预测因素
Liver Int. 2016 May;36(5):667-76. doi: 10.1111/liv.12929. Epub 2015 Aug 28.
9
Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy.经颈静脉肝内门体分流术治疗非肿瘤性肝硬化门静脉血栓形成抗凝治疗无效的安全性和疗效。
Dig Dis Sci. 2023 Jul;68(7):3174-3184. doi: 10.1007/s10620-023-07930-4. Epub 2023 May 12.
10
Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency.脾切除术后门静脉血栓形成的发生率及其对经颈静脉肝内门体分流术支架通畅性的影响。
World J Clin Cases. 2019 Sep 6;7(17):2450-2462. doi: 10.12998/wjcc.v7.i17.2450.

引用本文的文献

1
Transjugular Intrahepatic Portosystemic Shunt for Preventing Rebleeding of Esophageal Varices in Patients with Portal Cavernous Transformation.经颈静脉肝内门体分流术预防门静脉海绵样变性患者食管静脉曲张再出血
Dig Dis Sci. 2025 May;70(5):1897-1905. doi: 10.1007/s10620-025-08955-7. Epub 2025 Mar 3.
2
Case report: Management of liver cancer complicated by gastric varices rupture and bleeding: transjugular intrahepatic portosystemic shunt utilizing the mesenteric venous pathway.病例报告:肝癌合并胃静脉曲张破裂出血的治疗:经颈静脉肝内门体分流术采用肠系膜静脉途径
Front Med (Lausanne). 2024 Jun 19;11:1388584. doi: 10.3389/fmed.2024.1388584. eCollection 2024.
3

本文引用的文献

1
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis in cirrhosis.经颈静脉肝内门体分流术治疗肝硬化门静脉血栓形成
Gut. 2012 Feb;61(2):326-7. doi: 10.1136/gutjnl-2011-300577. Epub 2011 Jul 13.
2
Transjugular intrahepatic porto-systemic shunt placement in a patient with left-lateral split-liver transplant and mesenterico-left portal vein by pass placement.经颈静脉肝内门体分流术在左外叶劈离式肝移植并肠系膜左侧门静脉旁路术患者中的应用。
Cardiovasc Intervent Radiol. 2011 Dec;34(6):1316-9. doi: 10.1007/s00270-011-0199-6. Epub 2011 Jun 7.
3
Tips for portal vein thrombosis (pvt) in cirrhosis: not only unblocking a pipe.
Timing of TIPS for the management of portal vein thrombosis in liver cirrhosis.
经颈静脉肝内门体分流术(TIPS)用于肝硬化门静脉血栓形成管理的时机
J Transl Int Med. 2023 Dec 20;11(4):316-319. doi: 10.2478/jtim-2023-0095. eCollection 2023 Dec.
4
Efficacy of endovascular treatment for completely occlusive acute-subacute portal and mesenteric vein thrombosis with severe complications in patients without cirrhosis.急性-亚急性完全闭塞性门静脉和肠系膜静脉血栓形成伴严重并发症的非肝硬化患者的血管内治疗效果。
Jpn J Radiol. 2023 May;41(5):541-550. doi: 10.1007/s11604-022-01377-9. Epub 2023 Jan 21.
5
Primary Catheter-Directed Thrombolysis for Porto-Mesenteric Venous Thrombosis (PMVT) in Non-Cirrhotic Patients.非肝硬化患者门静脉肠系膜静脉血栓形成(PMVT)的原发性导管定向溶栓治疗
J Clin Med. 2022 Aug 12;11(16):4721. doi: 10.3390/jcm11164721.
6
Efficacy of interventional radiology in the management of portal hypertension: A narrative review.介入放射学在门静脉高压症管理中的疗效:一篇叙述性综述。
Medicine (Baltimore). 2022 Aug 19;101(33):e30018. doi: 10.1097/MD.0000000000030018.
7
Technical and Medium-Term Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt with Fluoroscopy and Additional Trans-abdominal Ultrasound Guidance.经颈静脉肝内门体分流术在透视及额外经腹超声引导下的技术及中期临床结果
Indian J Radiol Imaging. 2021 Nov 30;31(4):858-866. doi: 10.1055/s-0041-1735928. eCollection 2021 Oct.
8
Application of percutaneous transluminal sharp recanalization in transjugular intrahepatic portosystemic shunt for patients with chronic portal vein occlusion.经皮经肝穿刺腔内锐性再通术在经颈静脉肝内门体分流术治疗慢性门静脉闭塞中的应用。
Diagn Interv Radiol. 2021 Mar;27(2):257-262. doi: 10.5152/dir.2020.20461.
9
Warfarin prevented de novo portal vein thrombosis after transjugular intrahepatic portosystemic shunt: A retrospective study.华法林预防经颈静脉肝内门体分流术后新发门静脉血栓形成:一项回顾性研究。
Medicine (Baltimore). 2020 Jan;99(2):e18737. doi: 10.1097/MD.0000000000018737.
10
Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants.门静脉血栓形成的管理进展及新型抗凝剂的作用
J Clin Transl Hepatol. 2019 Jun 28;7(2):154-164. doi: 10.14218/JCTH.2018.00057.
肝硬化门静脉血栓形成(PVT)的治疗要点:不止于疏通管道
J Hepatol. 2011 Oct;55(4):945-6; author reply 947-8. doi: 10.1016/j.jhep.2011.02.027. Epub 2011 Mar 15.
4
Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.经颈静脉肝内门体分流术对肝硬化患者门静脉血栓形成的短期和长期影响。
Gut. 2011 Jun;60(6):846-52. doi: 10.1136/gut.2010.228023. Epub 2011 Feb 28.
5
Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis.闭塞性门静脉血栓形成作为失代偿性肝硬化的新标志物。
Med Hypotheses. 2011 Apr;76(4):522-6. doi: 10.1016/j.mehy.2010.12.007. Epub 2011 Jan 8.
6
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee.肝脏血管疾病:意大利肝病研究学会(AISF)特别委员会的建议。
Dig Liver Dis. 2011 Jul;43(7):503-14. doi: 10.1016/j.dld.2010.11.006. Epub 2010 Dec 24.
7
Stage of portal vein thrombosis.门静脉血栓形成阶段。
J Hepatol. 2011 May;54(5):1080-2; author reply 1082-3. doi: 10.1016/j.jhep.2010.10.034. Epub 2010 Dec 5.
8
Endovascular treatment for nonacute symptomatic portal venous thrombosis through intrahepatic portosystemic shunt approach.经肝内门体分流途径的非急性症状性门静脉血栓的血管内治疗。
J Vasc Interv Radiol. 2011 Jan;22(1):61-9. doi: 10.1016/j.jvir.2010.07.028. Epub 2010 Nov 24.
9
Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis.聚四氟乙烯覆膜支架与裸支架经颈静脉肝内门体分流术的通畅率和临床结局:荟萃分析。
J Gastroenterol Hepatol. 2010 Nov;25(11):1718-25. doi: 10.1111/j.1440-1746.2010.06400.x.
10
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.经颈静脉肝内门体分流术治疗肝硬化合并门静脉血栓形成并出现症状性门静脉高压。
J Hepatol. 2011 Jan;54(1):78-88. doi: 10.1016/j.jhep.2010.06.029. Epub 2010 Aug 27.